PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30975543-13	2019	Sorafenib, through AMPK, blocked the GDNF/AKT survival action without altering the RET apoptotic pathway.	Sorafenib	0-9	glial cell derived neurotrophic factor	Homo sapiens	37-41	
34072570-9	2021	In vitro experimental evidence suggested that sorafenib induced protein kinase RNA-like ER kinase (PERK)/activating transcription factor 4 (ATF4)-dependent ZFAS1 expression, and sorafenib resistance could be overcome by PERK/ATF inhibitors.	Sorafenib	46-55	glial cell derived neurotrophic factor	Homo sapiens	225-228	
34072570-9	2021	In vitro experimental evidence suggested that sorafenib induced protein kinase RNA-like ER kinase (PERK)/activating transcription factor 4 (ATF4)-dependent ZFAS1 expression, and sorafenib resistance could be overcome by PERK/ATF inhibitors.	Sorafenib	178-187	glial cell derived neurotrophic factor	Homo sapiens	225-228